GovChime
Notice ID: 12b3e638abf9494bafecf358427137ecAward NoticeAwardedArchived

Pegfilgrastim 6MG/.06ML with VMI

Awarded on March 19, 2025. Full description on SAM.gov.

Awarded tounder 75A50325C00002 (source: SAM.gov award notice)• $11.8M

Overview

Posted
March 20, 2025
Notice type
Award Notice
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of Health and Human Services

Notice details

Place of performance
Atlanta, GA
Last updated
Nov 16, 2026
First published
Last updated on SAM.gov
Award date
Mar 19, 2025
Award amount (SAM.gov award notice)
$11.8M

Identifiers

Solicitation number
75A50324R00004
Notice ID
12b3e638abf9494bafecf358427137ec
Award number (PIID)
75A50325C00002

Description

This requirement is for the procurement of Pegfilgrastim 6MG/.06ML injection solution in syringe or autoinjector format (INJ, SOLN, SYR, or Autoinjector) with the FDA approved indication for treatment of hematopoietic subsyndrome of acute radiation syndrome, and Vendor Managed Inventory (VMI) services.

Full description on SAM.gov

Award Overview

Award Number

75A50325C00002

Award Amount (SAM.gov award notice)

$11.8M

Award Date

Mar 19, 2025

Awardee

Awardee UEI

V13JDMAMELK8

Line Item Number

75A50325C00002

Original Solicitation

Notice ID: 12b3e638abf9494bafecf358427137ec

Posted Date: Mar 20, 2025

Original Response Deadline: Not specified

Contacts

Documents

No documents available.

Lifecycle

  1. 2
    Version 2Combined Synopsis/SolicitationArchived

    Pegfilgrastim with VMI

    Notice a06ddaf200304e6db341849ac1865456 on SAM.gov

  2. 5
    Version 5Award NoticeArchivedCurrent

    Type changed from Combined Synopsis/Solicitation to Award Notice

    Pegfilgrastim 6MG/.06ML with VMI

    Notice 12b3e638abf9494bafecf358427137ec on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75A50324R00004

Archive Date

Apr 3, 2025

Office Address

Atlanta, GA, 30341